Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doms

Showing results (311-320 of 335) with videos related to

Pageof 34
Sort By:
Science (New York, N.Y.)|December 4, 1998
Genetic acceleration of AIDS progression by a promoter variant of CCR5M P Martin, M Dean, M W Smith, et al.
Journal of Virology|July 1, 2011
Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteinsCraig B Wilen, Nicholas F Parrish, Jennifer M Pfaff, et al.
Journal of Virology|October 3, 2001
Functional and antigenic characterization of human, rhesus macaque, pigtailed macaque, and murine DC-SIGNF Baribaud, S Pöhlmann, T Sparwasser, et al.
Journal of Virology|April 1, 1997
Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutationS Rana, G Besson, D G Cook, et al.
JACC. Cardiooncology|June 17, 2026
Immune Profiling Identifies Inflammatory Signatures in Immune Checkpoint Inhibitor-Related MyocarditisDouglas Daoudlarian, Sarah Boughdad, Robin Bartolini, et al.
Cell|November 15, 1996
CD4-independent infection by HIV-2 is mediated by fusin/CXCR4M J Endres, P R Clapham, M Marsh, et al.
Nature|August 22, 1996
Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor geneM Samson, F Libert, B J Doranz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2024
Tocilizumab and immune signatures for targeted management of cytokine release syndrome in immune checkpoint therapyD Daoudlarian, A Segot, S Latifyan, et al.
Virology|November 28, 2006
A simian immunodeficiency virus V3 loop mutant that does not efficiently use CCR5 or common alternative coreceptors is moderately attenuated in vivoStefan Pöhlmann, Jan Münch, Sheriff Aziz, et al.
Open Forum Infectious Diseases|June 14, 2024
Second Time's the Charm? Assessing the Sensitivity and Yield of Inpatient Diagnostic Algorithms for Pulmonary Tuberculosis in a Low-Prevalence SettingCaitlin M Dugdale, Kimon C Zachary, Dustin S McEvoy, et al.
Pageof 34

Showing results (311-320 of 335) with videos related to

Sort By:
Pageof 34
Science (New York, N.Y.)|December 4, 1998
Genetic acceleration of AIDS progression by a promoter variant of CCR5M P Martin, M Dean, M W Smith, et al.
Journal of Virology|July 1, 2011
Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteinsCraig B Wilen, Nicholas F Parrish, Jennifer M Pfaff, et al.
Journal of Virology|October 3, 2001
Functional and antigenic characterization of human, rhesus macaque, pigtailed macaque, and murine DC-SIGNF Baribaud, S Pöhlmann, T Sparwasser, et al.
Journal of Virology|April 1, 1997
Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutationS Rana, G Besson, D G Cook, et al.
JACC. Cardiooncology|June 17, 2026
Immune Profiling Identifies Inflammatory Signatures in Immune Checkpoint Inhibitor-Related MyocarditisDouglas Daoudlarian, Sarah Boughdad, Robin Bartolini, et al.
Cell|November 15, 1996
CD4-independent infection by HIV-2 is mediated by fusin/CXCR4M J Endres, P R Clapham, M Marsh, et al.
Nature|August 22, 1996
Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor geneM Samson, F Libert, B J Doranz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2024
Tocilizumab and immune signatures for targeted management of cytokine release syndrome in immune checkpoint therapyD Daoudlarian, A Segot, S Latifyan, et al.
Virology|November 28, 2006
A simian immunodeficiency virus V3 loop mutant that does not efficiently use CCR5 or common alternative coreceptors is moderately attenuated in vivoStefan Pöhlmann, Jan Münch, Sheriff Aziz, et al.
Open Forum Infectious Diseases|June 14, 2024
Second Time's the Charm? Assessing the Sensitivity and Yield of Inpatient Diagnostic Algorithms for Pulmonary Tuberculosis in a Low-Prevalence SettingCaitlin M Dugdale, Kimon C Zachary, Dustin S McEvoy, et al.
Pageof 34